Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Line Nederby
Observed names:
L Nederby,
L. Nederby,
Nederby, L.,
Nederby, Line
Institutions:
University of Southern Denmark,
Vejle Sygehus,
Region of Southern Denmark,
Lillebaelt Hospital
Observed institutions:
University of Southern Denmark,
University of Aberdeen,
Aarhus University,
Aarhus University Hospital,
Rigshospitalet,
Vejle Sygehus,
Region of Southern Denmark,
Lillebaelt Hospital
show all 8
ORCID:
0000-0002-0101-328X
Observed ORCID:
0000-0002-0101-328X
OpenAlex ID:
A5024580720
Persistence of DNMT 3A mutations at long‐term remission in adult patients with AML
2014
·
Gro G. Pløen
, Line Nederby
, et al.
·
British Journal of Haematology
·
131
h MICL and CD 123 in combination with a CD 45/ CD 34/ CD 117 backbone – a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia
2013
·
Anne S. Roug
, Hanne Ø. Larsen
, et al.
·
British Journal of Haematology
·
60
PDF
Mapping the CLEC 12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC 12A‐related cancer stem cell biology
2018
·
Marie Bill
, Peter B. van Kooten Niekerk
, et al.
·
Journal of Cellular and Molecular Medicine
·
55
PDF
Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
2020
·
Jon Røikjær Henriksen
, Line Nederby
, et al.
·
Journal of Ovarian Research
·
44
PDF
Quantification of NK cell activity using whole blood: Methodological aspects of a new test
2018
·
Line Nederby
, Anders Jakobsen
, et al.
·
Journal of Immunological Methods
·
37
Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome
2016
·
Marie Toft‐Petersen
, Line Nederby
, et al.
·
British Journal of Haematology
·
36
PDF
The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy: NK cell suppression after IVIg treatment in CIDP
2011
·
A. B. Bohn
, L. Nederby
, et al.
·
European Journal of Neurology
·
30
Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia
2011
·
Christian W. Eskelund
, Line Nederby
, et al.
·
Leukemia Research
·
28
Sensitive Ligand-Based Protein Quantification Using Immuno-PCR: A Critical Review Of Single-Probe And Proximity Ligation Assays
2014
·
Marcus Celik Hansen
, Line Nederby
, et al.
·
BioTechniques
·
27
Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort
2021
·
Morten Borg
, Sara W.C. Wen
, et al.
·
Lung Cancer
·
24
PDF
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer
2019
·
Torben Frøstrup Hansen
, Line Nederby
, et al.
·
Translational Oncology
·
24
PDF
Description of an activity-based enzyme biosensor for lung cancer detection
2024
·
Paul W. Dempsey
, Cristina-Mihaela Sandu
, et al.
·
Communications Medicine
·
17
PDF
Revisiting CLEC 12A as leukaemic stem cell marker in AML : highlighting the necessity of precision diagnostics in patients eligible for targeted therapy
2018
·
Marie Bill
, Anni Aggerholm
, et al.
·
British Journal of Haematology
·
17
PDF
Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy
2024
·
Sinne Søberg Brun
, Torben Frøstrup Hansen
, et al.
·
Scientific Reports
·
16
PDF
NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
2023
·
Sara Witting Christensen Wen
, Line Nederby
, et al.
·
British Journal of Cancer
·
16
PDF
Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age
2014
·
Anne S. Roug
, Marcus C. Hansen
, et al.
·
British Journal of Haematology
·
16
Unraveling stem cell and progenitor subsets in autologous grafts according to methods of mobilization: implications for prediction of hematopoietic recovery
2014
·
Anne Stidsholt Roug
, Lea Bjerre Hokland
, et al.
·
Cytotherapy
·
16
Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia
2015
·
Line Nederby
, Anne S. Roug
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
14
The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia
2017
·
Marie Toft‐Petersen
, Anne Stidsholt Roug
, et al.
·
Cytometry Part B Clinical Cytometry
·
13
PDF
Blood natural killer cells during treatment in recurrent ovarian cancer
2020
·
Jon Røikjær Henriksen
, Line Nederby
, et al.
·
Acta Oncologica
·
11
PDF
Case report: Exome sequencing identifies T-ALL with myeloid features as a IKZF1-struck early precursor T-cell malignancy
2017
·
Marcus C. Hansen
, Line Nederby
, et al.
·
Leukemia Research Reports
·
8
PDF
Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide
2023
·
A. H. Zedan
, L. Nederby
, et al.
·
Scientific Reports
·
7
PDF
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients
2022
·
Morten Borg
, Sara Witting Christensen Wen
, et al.
·
Journal of International Medical Research
·
7
PDF
Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer
2021
·
Sara W. C. Wen
, Rikke F. Andersen
, et al.
·
Cancers
·
7
PDF
Nature and nurture: a case of transcending haematological pre‐malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B‐cell proliferations
2015
·
Marcus C. Hansen
, Charlotte G. Nyvold
, et al.
·
British Journal of Haematology
·
7
Show more works
View as search
Works count:
96
Citation count:
745
H-index:
16
I10-index:
20
Year
Topic
Type